Skip to content
2000
Volume 28, Issue 18
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Objective

This study aimed to explore the active components and potential mechanism of Tanre Qing Injection (TRQI) in the treatment of Acute Respiratory Distress Syndrome (ARDS) using network pharmacology, molecular docking, and animal experiments.

Methods

The targets of active ingredients were identified using the TCMSP and Swiss Target Prediction databases. The targets associated with ARDS were obtained from the GeneCards database, Mala card database, and Open Targets Platform. A Protein-protein Interaction network (PPI) was constructed, and the core targets were subjected to Gene Ontology (GO) function annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. Finally, molecular docking technology and a mouse model of lipopolysaccharide-induced acute lung injury validated the experimental results.

Results

The results of network pharmacology showed the active components of TRQI in the treatment of ARDS to be baicalin, chenodeoxycholic acid, oroxylin-A, and ursodeoxycholic acid, and the core targets to be TP53, ESR1, AKT1, JUN, and SRC. KEGG analysis showed 181 signaling pathways, primarily including the IL-17 signaling pathway, endocrine resistance, lipid metabolism, and atherosclerosis. Molecular docking results demonstrated that baicalin, chenodeoxycholic acid, oroxylin-A, and ursodeoxycholic acid in TRQI exhibited the strongest affinity for TP53, ESR1, and SRC. Furthermore, the results of animal experiments have indicated TRQI to have a significant inhibitory effect on inflammatory factors TNF-α, IL-1β, and IL-6, and effectively alleviate the pathological damage of ARDS to lung tissue.

Conclusion

TRQI may exert its therapeutic effects on ARDS through multiple targets and pathways, providing a research basis for its clinical application and further development.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073331156241029074305
2025-01-07
2025-12-14

  • From This Site

    /content/journals/cchts/10.2174/0113862073331156241029074305
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. HeY.Q. ZhouC.C. YuL.Y. WangL. DengJ. TaoY.L. ZhangF. ChenW.S. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.Pharmacol. Res.202116310522410.1016/j.phrs.2020.105224 33007416
     [Google Scholar]
  2. ShawT.D. McAuleyD.F. O’KaneC.M. Emerging drugs for treating the acute respiratory distress syndrome.Expert Opin. Emerg. Drugs2019241294110.1080/14728214.2019.1591369
     [Google Scholar]
  3. BosL.D.J. WareL.B. Acute respiratory distress syndrome: Causes, pathophysiology, and phenotypes.Lancet2022400103581145115610.1016/S0140‑6736(22)01485‑4 36070787
     [Google Scholar]
  4. LuytC.E. BouadmaL. MorrisA.C. DhananiJ.A. KollefM. LipmanJ. Martin-LoechesI. NseirS. RanzaniO.T. RoquillyA. SchmidtM. TorresA. TimsitJ.F. Pulmonary infections complicating ARDS.Intensive Care Med.202046122168218310.1007/s00134‑020‑06292‑z 33175277
     [Google Scholar]
  5. ZhangW. ZhouJ.l. Application progress of pulse indicator continuous cardiac output continuous monitoring in acute respiratory distress syndrome.Contemporary Med.20222821188191
     [Google Scholar]
  6. LuY. SongZ. ZhouX. HuangS. ZhuD. YangC. Bai, X.; Sun, B.; Spragg, R.; Spragg, R. A 12-month clinical survey of incidence and outcome of acute respiratory distress syndrome in Shanghai intensive care units.Intensive Care Med.200430122197220310.1007/s00134‑004‑2479‑y 15650866
     [Google Scholar]
  7. KillienE.Y. MillsB. WatsonR.S. VavilalaM.S. RivaraF.P. Morbidity and mortality among critically injured children with acute respiratory distress syndrome.Crit. Care Med.2019472e112e11910.1097/CCM.0000000000003525 30379667
     [Google Scholar]
  8. ChenW. ChenY.Y. TsaiC.F. ChenS.C.C. LinM.S. WareL.B. ChenC.M. Incidence and outcomes of acute respiratory distress syndrome.Medicine (Baltimore)20159443e184910.1097/MD.0000000000001849 26512593
     [Google Scholar]
  9. RubenfeldG.D. CaldwellE. PeabodyE. WeaverJ. MartinD.P. NeffM. SternE.J. HudsonL.D. Incidence and outcomes of acute lung injury.N. Engl. J. Med.2005353161685169310.1056/NEJMoa050333 16236739
     [Google Scholar]
  10. BosmaK.J. LewisJ.F. Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome.Expert Opin. Emerg. Drugs200712346147710.1517/14728214.12.3.461 17874973
     [Google Scholar]
  11. ImpellizzeriD. BruschettaG. EspositoE. CuzzocreaS. Emerging drugs for acute lung injury.Expert Opin. Emerg. Drugs2015201758910.1517/14728214.2015.1000299 25560706
     [Google Scholar]
  12. ChenL. LiJ. ZhuY. ZhaoT. GuoL. KangL. YuJ. DuH. LiuD. Weed Suppression and molecular mechanisms of isochlorogenic acid a isolated from Artemisia argyi extract via an activity-guided method.J. Agric. Food Chem.20227051494150610.1021/acs.jafc.1c06417 35089021
     [Google Scholar]
  13. WangL. TaoY.L. ChenW.S. Research progress on chemical constituents, pharmacological effects and clinical application of Tanre Qing Injection.Chin. Herb. Med.2020511233183328
     [Google Scholar]
  14. HeB. lu, J.Y.; lin, J.P. A meta-analysis of injection in the treatment of acute lung injury/acute respiratory distress syndrome.China Med. Emerg.2020290915521557
     [Google Scholar]
  15. LiG.X. DouJ. FangY. BuY.B. XinY. CaiY.N. ChangZ.Z. The efficacy of statins combined with Tanre Qing Injection in the treatment of sepsis with acute lung injury and its effect on peripheral blood HMGB1, IL-6, IL-17 and IL-33.Chin. J. Integr. Med.2021301617811786
     [Google Scholar]
  16. ZhaoN.B. WangD.X. DuX.H. Tanre Qing Injection in the treatment of respiratory diseases clinical application of new progress.Chin. Med. Emerg.2018274742f
     [Google Scholar]
  17. WangL. Discovery and evaluation of quality markers of Tanreqing injection based on real world evidence.Shanghai University of Traditional Chinese Medicine2021000069
     [Google Scholar]
  18. MannA. EarlyG.L. Acute respiratory distress syndrome.Mo. Med.20121095371375 23097941
     [Google Scholar]
  19. XiaoL.X. DengW. Research status and evaluation of major biomarkers of acute respiratory distress syndrome.Clin. Pulm. Med.2023281117531757
     [Google Scholar]
  20. HuangL.Y. NieL.X. KangS. Research Progress on the Chemical Constituents,Pharma-cological Effects and Quality Control of Huangqin (Scutellariae Radix).Liaoning Zhongyiyao Daxue Xuebao202426048896
     [Google Scholar]
  21. WangH. ChiQ. XiongS.L. The effect of honeysuckle extract on lung inflammation in LPS-induced ARDS rats.Guangdong Yaoxueyuan Xuebao20173303379382
     [Google Scholar]
  22. YanL. LaiY. Effect of Tanreqing Injection on NF-κB of Acute Lung Injury Induced by Endotoxin in Rats Lung Tissue. China.Med. Emerg.20152413840
     [Google Scholar]
  23. YangL.J. Protective effect of tanreqing injection on lung function and vascular endothelial function in acute lung injury.China J. Exp. Presc.20131907318320
     [Google Scholar]
  24. MaiH.Q. Clinical efficacy of Tanre Qing injection in the treatment of severe pulmonary contusion.Clin. Pulm. Med.2017220610821084
     [Google Scholar]
  25. WuW.J. ZengN. WangS.Y. Anti-inflammatory and lung function protective effects of baicalin on TLR4/NF-κB signaling pathway in mice with mycoplasma pneumonia.JHI20232335213526
     [Google Scholar]
  26. LiX. ChangH. ShiS.L. Research progress of TCM pathogenesis and treatment of pulmonary fibrosis. Pharmacology and clinical practice of traditional.Chin. Med.20213701240247
     [Google Scholar]
  27. LiB. WangH.M. Research progress of HMGB1 in the pulmonary fibrosis after ARDS.J. Zunyi Med. Univ.2023467725730
     [Google Scholar]
  28. ZhangL. XiR. ZangN.Z. Effects of Ursodeoxycholic acid on bleomycin-induced pulmonary fibrosis in rats by regulating TGF-β1/Smads signaling pathway.World J. Tradit. Chin. Med.20231802271276
     [Google Scholar]
  29. JiaH. ChenX.L. ChenC. Baicalin prevents up-regulation of connective tissue growth factor in the lungs of rats with pulmonary fibrosis.Wuli Xuebao20106206535540 21170500
     [Google Scholar]
  30. LiaoS.Y. CasanovaN.G. BimeC. CampS.M. LynnH. GarciaJ.G.N. Identification of early and intermediate biomarkers for ARDS mortality by multi-omic approaches.Sci. Rep.20211111887410.1038/s41598‑021‑98053‑1 34556700
     [Google Scholar]
  31. Al-RamliW. PréfontaineD. ChouialiF. MartinJ.G. OlivensteinR. LemièreC. HamidQ. TH17-associated cytokines (IL-17A and IL-17F) in severe asthma.J. Allergy Clin. Immunol.200912351185118710.1016/j.jaci.2009.02.024 19361847
     [Google Scholar]
  32. IwakuraY. NakaeS. SaijoS. IshigameH. The roles of IL‐17A in inflammatory immune responses and host defense against pathogens.Immunol. Rev.20082261577910.1111/j.1600‑065X.2008.00699.x 19161416
     [Google Scholar]
  33. JiangZ.Y. WangX.N. TangK.G. The sRNA derived from roasted licorice may alleviate lung injury in mild ADRS model mice by targeting TNF-α.Basic Med. Clin.2023430710301039
     [Google Scholar]
  34. SongT.R. ChenF. DongQ.M. The anti-inflammatory effect of arctiin on ARDS cell model and the effect of PI3K-AKT-NF-кB signaling pathway.J. Tradit. Chin. Med.20224606623628
     [Google Scholar]
  35. ZhuL. The effect of amiloride-mediated PI3K/AKT signaling pathway on lung injury in ARDS rats.Lanzhou University202010.27204/d.cnki.glzhu.2020.000517
     [Google Scholar]
  36. ShiY. WangY.C. YangZ. Effect of Xuanfei Zhisou Decoction on IL-17 signaling pathway in COPD model rats.China J. Exp. Presc.20243009283910.13422/j.cnki.syfjx.20240318
     [Google Scholar]
  37. LinZ.W. WuL.J. WuH.H. Mechanism of Zhishi Xiebai Guizhitang in Alleviating Myocardial Injury in Rats with Myocardial Infarction Based on TNF/NF-êB Signaling Pathway.China J. Exp. Presc.2023291881610.13422/j.cnki.syfjx.20230844
     [Google Scholar]
  38. GuoJ. ZhuJ. WangQ. WangJ. JiaY. Comparative efficacy of seven kinds of chinese medicine injections in acute lung injury and acute respiratory distress syndrome: A network meta-analysis of randomized controlled trials.Front. Pharmacol.20211262775110.3389/fphar.2021.627751 33767627
     [Google Scholar]
/content/journals/cchts/10.2174/0113862073331156241029074305
Loading
Exploration of the Mechanism of Tanre Qing Injection in Treating Acute Respiratory Distress Syndrome through Network Pharmacology, Molecular Docking, and Animal Experiments
Comb Chem High Throughput Screen 28, 3157 (2025); https://doi.org/10.2174/0113862073331156241029074305
/content/journals/cchts/10.2174/0113862073331156241029074305
/content/journals/cchts/10.2174/0113862073331156241029074305
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): ARDS in mice; molecular docking; mortality; network pharmacology; respiratory distress syndrome; Tanre Qing injection

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test